Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.

Brody AL, Mandelkern MA, Olmstead RE, Allen-Martinez Z, Scheibal D, Abrams AL, Costello MR, Farahi J, Saxena S, Monterosso J, London ED.

Neuropsychopharmacology. 2009 Jan;34(2):282-9. doi: 10.1038/npp.2008.87. Epub 2008 Jun 18.

2.

Smoking-induced ventral striatum dopamine release.

Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, Lee GS, Huang J, Hahn EL, Mandelkern MA.

Am J Psychiatry. 2004 Jul;161(7):1211-8.

PMID:
15229053
3.

Denicotinized versus average nicotine tobacco cigarette smoking differentially releases striatal dopamine.

Domino EF, Ni L, Domino JS, Yang W, Evans C, Guthrie S, Wang H, Koeppe RA, Zubieta JK.

Nicotine Tob Res. 2013 Jan;15(1):11-21. doi: 10.1093/ntr/nts029. Epub 2012 Apr 5.

5.

Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.

Scott DJ, Domino EF, Heitzeg MM, Koeppe RA, Ni L, Guthrie S, Zubieta JK.

Neuropsychopharmacology. 2007 Feb;32(2):450-7. Epub 2006 Nov 8.

6.

Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence.

Brody AL, London ED, Olmstead RE, Allen-Martinez Z, Shulenberger S, Costello MR, Abrams AL, Scheibal D, Farahi J, Shoptaw S, Mandelkern MA.

Psychiatry Res. 2010 Sep 30;183(3):218-24. doi: 10.1016/j.pscychresns.2009.06.004. Epub 2010 Aug 3.

7.

Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.

Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT.

Arch Gen Psychiatry. 2006 Jul;63(7):808-16.

8.

The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study.

Montgomery AJ, Lingford-Hughes AR, Egerton A, Nutt DJ, Grasby PM.

Synapse. 2007 Aug;61(8):637-45.

PMID:
17492764
9.

Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study.

Takahashi H, Fujimura Y, Hayashi M, Takano H, Kato M, Okubo Y, Kanno I, Ito H, Suhara T.

Int J Neuropsychopharmacol. 2008 May;11(3):413-7. Epub 2007 Oct 22.

PMID:
17949514
10.

Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET.

Gallezot JD, Kloczynski T, Weinzimmer D, Labaree D, Zheng MQ, Lim K, Rabiner EA, Ridler K, Pittman B, Huang Y, Carson RE, Morris ED, Cosgrove KP.

Neuropsychopharmacology. 2014 Mar;39(4):866-74. doi: 10.1038/npp.2013.286. Epub 2013 Oct 15.

11.

Effect of a history of major depressive disorder on smoking-induced dopamine release.

Brody AL, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, Saxena S, Farahi J, London ED, Mandelkern MA.

Biol Psychiatry. 2009 Nov 1;66(9):898-901. doi: 10.1016/j.biopsych.2009.06.011. Epub 2009 Jul 29.

12.

Reliability of striatal [¹¹C]raclopride binding in smokers wearing transdermal nicotine patches.

Yoder KK, Albrecht DS, Kareken DA, Federici LM, Perry KM, Patton EA, Zheng QH, Mock BH, O'Connor SJ, Herring CM.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):220-5. doi: 10.1007/s00259-011-1965-z. Epub 2011 Oct 19.

13.

Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.

Brody AL, Mandelkern MA, Costello MR, Abrams AL, Scheibal D, Farahi J, London ED, Olmstead RE, Rose JE, Mukhin AG.

Int J Neuropsychopharmacol. 2009 Apr;12(3):305-16. doi: 10.1017/S146114570800922X. Epub 2008 Aug 18.

14.

Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.

Donny EC, Jones M.

Drug Alcohol Depend. 2009 Sep 1;104(1-2):23-33. doi: 10.1016/j.drugalcdep.2009.01.021. Epub 2009 May 15.

15.

Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study.

Wing VC, Payer DE, Houle S, George TP, Boileau I.

Neuropsychopharmacology. 2015 May;40(6):1417-27. doi: 10.1038/npp.2014.327. Epub 2014 Dec 15.

16.

Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.

Nuechterlein EB, Ni L, Domino EF, Zubieta JK.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Aug 1;69:69-77. doi: 10.1016/j.pnpbp.2016.04.006. Epub 2016 Apr 17.

PMID:
27095017
17.

In vivo brain imaging of human exposure to nicotine and tobacco.

Sharma A, Brody AL.

Handb Exp Pharmacol. 2009;(192):145-71. doi: 10.1007/978-3-540-69248-5_6. Review.

18.

Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.

Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C.

Arch Gen Psychiatry. 2006 Dec;63(12):1386-95.

PMID:
17146013
19.

Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study.

Urban NB, Slifstein M, Thompson JL, Xu X, Girgis RR, Raheja S, Haney M, Abi-Dargham A.

Biol Psychiatry. 2012 Apr 15;71(8):677-83. doi: 10.1016/j.biopsych.2011.12.018. Epub 2012 Jan 29.

20.

Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes.

Brauer LH, Cramblett MJ, Paxton DA, Rose JE.

Psychopharmacology (Berl). 2001 Dec;159(1):31-7. Epub 2001 Sep 4.

PMID:
11797066

Supplemental Content

Support Center